Life Science (UK) Analysis

LABS Stock   34.70  0.20  0.57%   
Life Science REIT is overvalued with Real Value of 30.83 and Hype Value of 34.42. The main objective of Life Science stock analysis is to determine its intrinsic value, which is an estimate of what Life Science REIT is worth, separate from its market price. There are two main types of Life Science's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Life Science's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Life Science's stock to identify patterns and trends that may indicate its future price movements.
The Life Science stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Life Science is usually not traded on Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ). Life Stock trading window is adjusted to Europe/London timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Life Science REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Life Stock Analysis Notes

About 70.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.46. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Life Science REIT recorded a loss per share of 0.11. The entity last dividend was issued on the 3rd of October 2024. To find out more about Life Science REIT contact the company at 44 20 7945 9566 or learn more at https://www.lifesciencereit.co.uk.

Life Science Quarterly Total Revenue

5.02 Million

Life Science REIT Investment Alerts

Life Science REIT generated a negative expected return over the last 90 days
Life Science REIT has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 19.94 M. Net Loss for the year was (21.71 M) with profit before overhead, payroll, taxes, and interest of 1.28 M.
About 70.0% of the company shares are owned by institutional investors

Life Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 128.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Life Science's market, we take the total number of its shares issued and multiply it by Life Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Life Profitablity

Life Science's profitability indicators refer to fundamental financial ratios that showcase Life Science's ability to generate income relative to its revenue or operating costs. If, let's say, Life Science is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Life Science's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Life Science's profitability requires more research than a typical breakdown of Life Science's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.5 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.5.

Management Efficiency

Life Science REIT has return on total asset (ROA) of 0.014 % which means that it generated a profit of $0.014 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1377) %, meaning that it generated substantial loss on money invested by shareholders. Life Science's management efficiency ratios could be used to measure how well Life Science manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Life Science's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 17 M in 2025, whereas Total Assets are likely to drop slightly above 447.3 M in 2025.
Leadership effectiveness at Life Science REIT is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield
0.0545
Operating Margin
0.5048
Profit Margin
(1.99)
Forward Dividend Yield
0.0542
Beta
0.019

Technical Drivers

As of the 10th of January, Life Science secures the Standard Deviation of 1.63, risk adjusted performance of (0.08), and Mean Deviation of 1.17. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Life Science REIT, as well as the relationship between them. Please verify Life Science REIT standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if Life Science REIT is priced some-what accurately, providing market reflects its recent price of 34.7 per share.

Life Science REIT Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Life Science middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Life Science REIT. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Life Science Outstanding Bonds

Life Science issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Life Science REIT uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Life bonds can be classified according to their maturity, which is the date when Life Science REIT has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Life Science Predictive Daily Indicators

Life Science intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Life Science stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Life Science Forecast Models

Life Science's time-series forecasting models are one of many Life Science's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Life Science's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Life Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Life Science prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Life shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Life Science. By using and applying Life Stock analysis, traders can create a robust methodology for identifying Life entry and exit points for their positions.
Life Science is entity of United Kingdom. It is traded as Stock on LSE exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Life Science to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Additional Tools for Life Stock Analysis

When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.